Free Access
Med Sci (Paris)
Volume 32, Number 6-7, Juin–Juillet 2016
Page(s) 606 - 611
Section M/S Revues
Published online 12 July 2016
  1. Clement LC, Avila-Casado C, Macé C, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011 ; 17 : 117–122. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Nachman PH, Jennett JC, Falk RJ. Primary glomerular disease. In : Taal MW, Chertow GM, Marsden PA, et al., eds, The kidney 9th ed. Philadelphia : Elsevier, 2012 : 1100–1191. [Google Scholar]
  3. Faul C, Donnelly M, Merscher-Gomez S, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008 ; 14 : 931–938. [CrossRef] [PubMed] [Google Scholar]
  4. Müller-Deile J, Schiffer M. Podocyte directed therapy of nephrotic syndrome – can we bring the inside out? Pediatr Nephrol 2015 ; 31 : 393–405. [CrossRef] [PubMed] [Google Scholar]
  5. Macé C, Clément LC. Implication d’Angptl4 dans le syndrome néphrotique. Med Sci (Paris) 2014 ; 30 : 605–607. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Brideau G, Doucet A. Over-expression of adenosine deaminase in mouse podocytes does not reverse puromycin aminonucleoside resistance. BMC Nephrol 2010 ; 11 : 15. [CrossRef] [PubMed] [Google Scholar]
  7. Zhang H, Schin M, Saha J, et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am J Physiol Renal Physiol 2010 ; 299 : F91–F98. [CrossRef] [PubMed] [Google Scholar]
  8. Michael AF, Blau E, Vernier RL. Glomerular polyanion. Alteration in aminonucleoside nephrosis. Lab Invest 1970 ; 23 : 649–657. [Google Scholar]
  9. Miner JH. Glomerular filtration: the charge debate charges ahead. Kidney Int 2008 ; 74 : 259–261. [CrossRef] [PubMed] [Google Scholar]
  10. Bertozzi CR, Freeze HH, Varki A, Esko JD. Glycans in biotechnology and the pharmaceutical industry. In : Varki A, Cummings RD, Esko JD, et al., eds, Essentials of glycobiology, 2nd Edn. New York : Cold Spring Harbor Press, 2009 : 719–732. [Google Scholar]
  11. Varki A, Schauer R, Varki A, Cummings RD, Esko JD, et al. Sialic acids. Essentials of glycobiology, 2nd Edn. New York : Cold Spring Harbor Press, 2009 : 199–217. [Google Scholar]
  12. Chou HH, Takematsu H, Diaz S, et al. A mutation in human CMP-sialic acid hydroxylase occurred after the Homo-Pan divergence. Proc Natl Acad Sci USA 1998 ; 95 : 11751–11756. [CrossRef] [Google Scholar]
  13. Chugh SS, Clement LC, Macé C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 2012 ; 59 : 284–292. [CrossRef] [PubMed] [Google Scholar]
  14. Luchansky SJ, Yarema KJ, Takahashi S, Bertozzi CR. GlcNAc 2-epimerase can serve a catabolic role in sialic acid metabolism. J Biol Chem 2003 ; 278 : 8035–8042. [CrossRef] [PubMed] [Google Scholar]
  15. Malicdan MC, Noguchi S, Hayashi YK, et al. Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model. Nat Med 2009 ; 15 : 690–695. [CrossRef] [PubMed] [Google Scholar]
  16. Clement LC, Macé C, Avila-Casado C, et al. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 2014 ; 20 : 37–46. [CrossRef] [PubMed] [Google Scholar]
  17. Koliwad SK, Kuo T, Shipp LE, et al. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism. J Biol Chem 2009 ; 284 : 25593–25601. [CrossRef] [PubMed] [Google Scholar]
  18. Koskimies O, Vilska J, Rapola J, Hallman N. Long-term outcome of primary nephrotic syndrome. Arch Dis Child 1982 ; 57 : 544–548. [CrossRef] [PubMed] [Google Scholar]
  19. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr.. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 1997 ; 8 : 769–776. [PubMed] [Google Scholar]
  20. Chugh SS, Macé C, Clément LC, et al. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol 2014 ; 5 : 23. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.